Hydrogel-Forming Microneedles in the Management of Dermal Disorders Through a Non-Invasive Process: A Review
Gels,
Journal Year:
2024,
Volume and Issue:
10(11), P. 719 - 719
Published: Nov. 7, 2024
Microneedle
(MN)
technology
has
emerged
as
a
promising
approach
for
delivering
therapeutic
agents
to
the
skin,
offering
significant
potential
in
treating
various
dermal
conditions.
Among
these
technologies,
hydrogel-forming
microneedles
(HFMNs)
represent
transformative
advancement
management
of
diseases
through
non-invasive
drug
delivery.
These
innovative
devices
consist
micrometer-sized
needles
made
native
or
crosslinked
hydrophilic
polymers,
capable
penetrating
stratum
corneum
without
damaging
underlying
tissues.
Upon
insertion,
HFMNs
rapidly
absorb
interstitial
fluid,
swelling
form
hydrogel
conduit
that
enables
efficient
transport
directly
into
microcirculation.
The
nature
enhances
patient
compliance
by
eliminating
pain
and
discomfort
associated
with
traditional
hypodermic
needles.
This
allows
delivery
wide
range
drugs,
including
macromolecules
biomacromolecules,
which
are
often
difficult
administer
dermally
due
their
size
polarity.
Moreover,
provide
controlled
regulated
release
profiles,
enabling
sustained
effects
while
minimizing
systemic
side
effects.
Additionally,
can
be
used
both
real-time
fluid
monitoring,
valuable
insights
disease
states
treatment
responses.
dual
functionality
positions
versatile
dermatology
tool
effectively
addressing
complications.
review
explores
use
polymeric
biomaterials
HFMN
fabrication
application
major
disorders,
such
acne,
psoriasis,
other
skin
Furthermore,
highlights
MN-based
treatments,
underscoring
reduce
improve
adherence,
supported
recent
literature.
Language: Английский
Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
Rashmi Hulimane Shivaswamy,
No information about this author
Pranav Binulal,
No information about this author
Aloysious Benoy
No information about this author
et al.
ACS Materials Au,
Journal Year:
2024,
Volume and Issue:
5(1), P. 115 - 140
Published: Nov. 28, 2024
The
delivery
of
molecules,
such
as
DNA,
RNA,
peptides,
and
certain
hydrophilic
drugs,
across
the
epidermal
barrier
poses
a
significant
obstacle.
Microneedle
technology
has
emerged
prominent
area
focus
in
biomedical
research
because
its
ability
to
deliver
wide
range
biomolecules,
vaccines,
medicines,
other
substances
through
skin.
Microneedles
(MNs)
form
microchannels
by
disrupting
skin's
structure,
which
compromises
function,
facilitating
easy
penetration
drugs
into
These
devices
enhance
administration
many
therapeutic
skin,
enhancing
their
stability.
Transcutaneous
medications
using
microneedle
patch
offers
advantages
over
conventional
drug
methods.
containing
active
can
be
stimulated
different
internal
external
factors
result
regulated
release
substances.
To
achieve
efficient
desired
location,
it
is
necessary
consider
design
needles
with
appropriate
optimized
characteristics.
choice
materials
for
developing
manufacturing
these
vital
determining
pharmacodynamics
pharmacokinetics
delivery.
This
article
provides
most
recent
update
overview
numerous
systems
that
utilize
activators
stimulate
components
from
microneedles.
Further,
discusses
utilized
producing
microneedles
strategies
important
managing
drugs.
An
explanation
commonly
employed
fabrication
techniques
applications
electronics,
particularly
integrated
systems,
discussed.
successfully
implement
clinical
settings,
essential
comprehensively
assess
several
factors,
biocompatibility,
stability,
safety,
production
cost.
Finally,
an
in-depth
review
criteria
difficulties
potential
future
direction
delivering
monitoring
diseases
explored.
Language: Английский